Get access

Management of ungual warts

Authors

  • Jordana Herschthal,

    1. Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
    Search for more papers by this author
  • Michael P. McLeod,

    1. Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
    Search for more papers by this author
  • Martin Zaiac

    Corresponding author
    1. Greater Miami Skin and Laser Center, Miami Beach, Miami, Florida
    • Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
    Search for more papers by this author

Address correspondence and reprint requests to: Martin Zaiac, MD, Chairman, Department of Dermatology, Herbert Wertheim College of Medicine, Florida International University, Director, Greater Miami Skin and Laser Center, Mount Sinai Medical Center, 4308 Alton Road, Suite 750, Miami Beach, FL 33140, or email: drmartyz@aol.com.

Abstract

Warts are the most common nail tumor generally caused by human papilloma virus (HPV) 1, 2, 4, 27, and 57. HPV 16 and 18 are associated with malignant transformation to squamous cell carcinoma, while HPV 2 and 7 are associated with “butcher's warts.” Current treatments range from topical and intralesional therapies to systemic agents and surgical procedures. Despite the numerous available possibilities for treatment, intralesional bleomycin appears to be the most effective treatment for periungual warts.

Get access to the full text of this article

Ancillary